Effect of Thymoglobulin Versus Basiliximab on Regulatory T Cell Function in Live Donor Kidney Transplant Recipients
Condition: KIDNEY TRANSPLANTATION
Interventions: Drug: Basiliximab; Drug: Thymoglobulin
Sponsor: University of Pennsylvania
Suspended - verified March 2016
Interventions: Drug: Basiliximab; Drug: Thymoglobulin
Sponsor: University of Pennsylvania
Suspended - verified March 2016
News Type: